Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET / CT”

2,035 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,035 results

Not applicableLooking for participantsNCT06023186
What this trial is testing

Effect of Mavacamten Treatment on Coronary Flow Reserve in oHCM

Who this might be right for
Obstructive Hypertrophic Cardiomyopathy
Michael Ayers 20
Not applicableLooking for participantsNCT06690983
What this trial is testing

Tau PET/CT in Various Tau-Related Disease Patients

Who this might be right for
TauopathiesNeurodegenerative DiseasesNeurodegeneration
Tianjin Medical University 500
Very early researchUnknownNCT02691169
What this trial is testing

Integrated 18F-labelled PSMA Project

Who this might be right for
Prostate Cancer
St. Joseph's Healthcare Hamilton 10
Not applicableEnded earlyNCT05742269
What this trial is testing

Molecular PD-L1 PET/CT Imaging With 89Zr-atezolizumab in Metastatic Triple Negative Breast Cancer

Who this might be right for
Metastatic Triple-Negative Breast Carcinoma
Karolinska University Hospital 3
Not applicableStudy completedNCT05611905
What this trial is testing

Biodistribution and Pathophysiology Study of 11C-para-aminobenzoic Acid

Who this might be right for
Renal ExcretionBacterial InfectionsInflammatory Disease+1 more
Johns Hopkins University 13
Not applicableStudy completedNCT06960031
What this trial is testing

Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation

Who this might be right for
PET/CTHepatocellular MalignancyRadiofrequency Ablation
Tanta University 70
Not applicableUnknownNCT01432002
What this trial is testing

FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer

Who this might be right for
Breast Neoplasm
University Hospital, Geneva 60
Very early researchLooking for participantsNCT07273188
What this trial is testing

68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease

Who this might be right for
Crohn's DiseaseIntestinal FibrosisInflamatory Bowel Disease+1 more
Mayo Clinic 45
Not applicableUnknownNCT01089270
What this trial is testing

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Not applicableLooking for participantsNCT07605156
What this trial is testing

Diagnostic Value of 68Ga-Pentixafor PET/CT in Adrenal Tumors With Aldosterone and Cortisol Cosecretion

Who this might be right for
Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
Peking University First Hospital 130
Very early researchUnknownNCT02817945
What this trial is testing

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

Who this might be right for
Lung CancerNeuroendocrine Neoplasm
Peking Union Medical College Hospital 100
Early research (Phase 1)WithdrawnNCT02193672
What this trial is testing

A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT07660939
What this trial is testing

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

Who this might be right for
Plasma Cell DisordersMultiple Myeloma (MM)
Peking University First Hospital 50
Testing effectiveness (Phase 2)UnknownNCT03116945
What this trial is testing

Novel Gallium Imaging in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Rutgers, The State University of New Jersey 18
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT04318561
What this trial is testing

Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)UnknownNCT03951337
What this trial is testing

64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum)

Who this might be right for
Rectal Cancer
Institut Cancerologie de l'Ouest 70
Very early researchUnknownNCT02485886
What this trial is testing

68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Peking Union Medical College Hospital 20
Not applicableLooking for participantsNCT06716294
What this trial is testing

Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation

Who this might be right for
Bone Cancer MetastaticRadiofrequency AblationSpine Metastases+1 more
National and Kapodistrian University of Athens 16
Next Page